反电荷的多糖纳米纤维涂上带有静血潜力的带
Ziying Wang1, Xinwei Zheng1, Qinhui Chen1
1Fujian Provincial Key Laboratory of Polymer Materials, College of Chemistry and Materials Science, Fujian Normal University, Fujian 350007, China.
International journal of biological macromolecules
|July 22, 2025
概括
新的QCS/HADA@gauze纳米纤维通过形成物理屏障和捕获血液成分来增强血液静止. 这种先进的材料提供了卓越的出血控制和易于移除,优于传统的选择.
科学领域:
- 生物材料科学 生物材料科学
- 织工程 织工程 织工程
- 血液静止研究 血液静止研究
背景情况:
- 棉是一种常见的止血材料,但在控制严重出血方面存在局限性.
- 需要先进的静血材料,提高疗效和组织粘附性.
研究的目的:
- 开发和评估一种新型的血液静止,其功能与四元化奇托 (QCS) 和甲基醇功能化氨酸 (HADA) 纳米纤维.
- 为了研究QCS/HADA@gauze的静血机制,组织粘附性和生物相容性.
主要方法:
- 通过在棉上沉积相反电荷的纳米纤维来制造QCS/HADA@气.
- 通过凝血和出血模型评估静血性能.
- 使用NaCl溶液评估组织粘附度和易去除性.
主要成果:
- QCS/HADA@gauze证明了物理屏障的快速形成和血液成分的有效捕获.
- 与传统的棉和Combat GauzeTM相比,该材料表现出优越的静血性能.
- 观察到增强的组织粘附性和易于用NaCl溶液去除. 该材料还显示出出色的生物相容性和抗菌活性.
结论:
- 开发的QCS/HADA@gauze提供了双重静血机制,提高了有效性和粘附性.
- 这种新型的静血组织为先进的伤口管理和出血控制提供了一个有希望的策略.
相关概念视频
Glycosaminoglycans
5.1K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
5.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
913
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
913
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K


